Results 91 to 100 of about 70,237 (252)
THE EPIDEMIC OF DENGUE FEVER AT SMYRNA. [PDF]
, 1890 Alex. Stamatiades +6 more
openalex +1 more source
Flagellins as Vaccine Adjuvants and Cancer Immunotherapy: Recent Advances and Future Prospects
Immunology, Volume 176, Issue 3, Page 277-303, November 2025.The figure depicts the role of flagellin in immune cells. Flagellin interacts with TLR5, resulting in the formation of homodimers and the recruitment of MyD88, which activates the IκB and MAPK signalling pathways. This results in the activation of NF‐κB and AP‐1, producing TNF‐α, IL‐6, IL‐8, and IL‐12.
Asma Talukder +4 more
wiley +1 more source
APLIKASI HEALTH BELIEF MODEL PADA PERILAKU PENCEGAHAN DEMAM BERDARAH DENGUE
Jurnal Promkes: The Indonesian Journal of Health Promotion and Health Education, 2018 Dengue fever is an acute fever disease that caused by dengue virus by the bite of mosquito of the genus aedes. In Indonesia, large number of dengue fever was fluctuatited every year, including East Java. One of large number cases is the Kediri.
Helmy Bachtiar Attamimy +1 more
doaj +1 more source
Should We Advance Our Understanding of Immunoglobulin E in Viral Immunity?
Immunology, Volume 176, Issue 3, Page 312-321, November 2025.Immunoglobulin E has been extensively studied in allergies and parasitic diseases. Antigen‐specific IgE has been identified as part of the humoral response to viruses. This revision speculates on possible functionalities for IgE, such as neutralisation, cytotoxicity and immunopathology of viral diseases, and provide insights about gaps to fill in ...
Amanda Izeli Portilho +3 more
wiley +1 more source
Heterotypic Serologic Responses after Yellow Fever Vaccination; Detection of Persons with Past St. Louis Encephalitis or Dengue [PDF]
, 1967 William L. Pond +3 more
openalex +1 more source
From Lab to Market: Paper‐Based CRISPR Diagnostics and Commercialization Pathways
Advanced Sensor Research, Volume 4, Issue 10, October 2025.Paper‐based CRISPR diagnostics represents one of the most widely commercialized CRISPR assay technologies, yet challenges remain for broader point‐of‐care use. Abstract The global health landscape is continually challenged by infectious diseases that can swiftly escalate into pandemics, underscoring the need for rapid, accurate, and cost‐effective ...
Selen Dalgan, Qingshan Wei
wiley +1 more source
American Journal of Primatology, Volume 87, Issue 10, October 2025.Neopterin is a sensitive and specific biomarker of intracellular pathogen infection and chronic inflammation, and affected by environmental, life‐history, and sex‐contextual factors. This review offers best‐practice guidelines and practical advice on sample collection, storage, and analysis in primates when used for ecoimmunological conservation and ...
Verena Behringer, Caroline Deimel
wiley +1 more source
Clinical Case Reports, Volume 13, Issue 10, October 2025.ABSTRACT Exertional rhabdomyolysis can rapidly progress to acute kidney injury requiring dialysis, even in young healthy athletes. Delayed presentation and inadequate hydration increase risk. Clinicians should suspect rhabdomyolysis in patients with myalgia, dark urine, or oliguria after strenuous exercise, and initiate early hydration and electrolyte ...
Musawer Khan +8 more
wiley +1 more source
Journal of Medical Virology, Volume 97, Issue 10, October 2025.ABSTRACT Chikungunya virus (CHIKV) infection can trigger a sustained inflammatory response, often leading to chronic musculoskeletal pain. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) may contribute to the persistence of arthralgia through their involvement in joint tissue remodeling and degradation. This study aimed to evaluate
Ana Clara Santos Costa +9 more
wiley +1 more source
The Sweet Aspects of Orthoflavivirus Treatment Design and Vaccine Development
Journal of Medical Virology, Volume 97, Issue 10, October 2025.ABSTRACT Viruses in the genus Orthoflavivirus are among the most important human pathogens because of their significant public health impact. Many strategies have been proposed to develop specific or broad‐spectrum treatments and preventive measures for these viral infections in humans.
Ana C. Alcalá +2 more
wiley +1 more source